BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15262512)

  • 1. An update from the latest workshop on asymptomatic primary hyperparathyroidism.
    Lendel I; Horwith M
    Otolaryngol Clin North Am; 2004 Aug; 37(4):737-49, viii. PubMed ID: 15262512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do the National Institutes of Health consensus guidelines for parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism?
    Sywak MS; Knowlton ST; Pasieka JL; Parsons LL; Jones J
    Surgery; 2002 Dec; 132(6):1013-9; discussion 1019-20. PubMed ID: 12490849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of asymptomatic primary hyperparathyroidism. New North American guidelines discussed from a Swedish perspective].
    Nilsson IL; Lundgren E; Ekbom A; Ljunghall S; Rastad J
    Lakartidningen; 2003 Nov; 100(47):3848-50, 3853-4. PubMed ID: 14719237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for operative intervention in patients with asymptomatic primary hyperparathyroidism: practice patterns of endocrine surgery.
    Kouvaraki MA; Greer M; Sharma S; Beery D; Armand R; Lee JE; Evans DB; Perrier ND
    Surgery; 2006 Apr; 139(4):527-34. PubMed ID: 16627063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical management of primary hyperparathyroidism and thresholds for surgical referral: a national study examining concordance between practice patterns and consensus panel recommendations.
    Mahadevia PJ; Sosa JA; Levine MA; Zeiger MA; Powe NR
    Endocr Pract; 2003; 9(6):494-503. PubMed ID: 14715476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of asymptomatic primary hyperparathyroidism: a commentary.
    Lawrence GD
    Md Med J; 1992 Jan; 41(1):58-61. PubMed ID: 1734166
    [No Abstract]   [Full Text] [Related]  

  • 7. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.
    Bilezikian JP; Potts JT; Fuleihan Gel-H; Kleerekoper M; Neer R; Peacock M; Rastad J; Silverberg SJ; Udelsman R; Wells SA
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N2-11. PubMed ID: 12412771
    [No Abstract]   [Full Text] [Related]  

  • 8. Consensus conference. Diagnosis and management of asymptomatic primary hyperparathyroidism. National Institutes of Health.
    Conn Med; 1991 Jun; 55(6):349-54. PubMed ID: 1935056
    [No Abstract]   [Full Text] [Related]  

  • 9. [Surgical indications of primary hyperparathyroidism].
    Tominaga Y
    Clin Calcium; 2005 Dec; 15(12):79-84. PubMed ID: 16322678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement.
    Ann Intern Med; 1991 Apr; 114(7):593-7. PubMed ID: 1900404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited?
    Eigelberger MS; Cheah WK; Ituarte PH; Streja L; Duh QY; Clark OH
    Ann Surg; 2004 Apr; 239(4):528-35. PubMed ID: 15024314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited?
    Solorzano CC; Irvin GL
    Ann Surg; 2005 Feb; 241(2):381-2. PubMed ID: 15650651
    [No Abstract]   [Full Text] [Related]  

  • 13. The NIH Consensus Development Program. The evolution of guidelines.
    Ferguson JH
    Int J Technol Assess Health Care; 1996; 12(3):460-74. PubMed ID: 8840666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Panelists' views of 68 NIH consensus conference.
    Ferguson JH; Sherman CR
    Int J Technol Assess Health Care; 2001; 17(4):542-58. PubMed ID: 11758298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic controversies in primary hyperparathyroidism.
    Silverberg SJ; Bilezikian JP; Bone HG; Talpos GB; Horwitz MJ; Stewart AF
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2275-85. PubMed ID: 10404790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of asymptomatic primary hyperparathyroidism. National Institutes of Health Consensus Development Conference. October 29-31, 1990.
    Consens Statement; 1990 Oct 29-31; 8(7):1-18. PubMed ID: 1669025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report of the National Institutes of Health (NIH) Workshop on the Development of Research Priorities in Eating Disorders.
    Grilo CM; Devlin MJ; Cachelin FM; Yanovski SZ
    Psychopharmacol Bull; 1997; 33(3):321-33. PubMed ID: 9550875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism.
    Bolland MJ; Grey AB; Orr-Walker BJ; Horne AM; Evans MC; Clearwater JM; Gamble GD; Reid IR
    N Z Med J; 2008 Jul; 121(1277):18-29. PubMed ID: 18677327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health implications of obesity: an NIH Consensus Development Conference.
    Burton BT; Foster WR
    J Am Diet Assoc; 1985 Sep; 85(9):1117-21. PubMed ID: 4031328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience.
    Grant CS; Thompson G; Farley D; van Heerden J
    Arch Surg; 2005 May; 140(5):472-8; discussion 478-9. PubMed ID: 15897443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.